TRT on TikTok: separating gym culture claims from clinical evidence

What did @jonasdundjakob actually say?

Honestly? Nothing coherent. The transcript reads like a failed auto-transcription of a non-English speaker or a heavily distorted audio capture. Phrases like "if you have a kind of radiator, you won't be able to make the case without worrying" and "we will kind of put blame it on it" carry zero extractable medical meaning.

The video is tagged with #trt and the caption points viewers to an Instagram highlight about "our therapy," which suggests this creator is discussing testosterone replacement therapy in some capacity. But nothing in the transcript itself confirms, explains, or claims anything about TRT, testosterone levels, hypogonadism, dosing, or clinical outcomes. We cannot fact-check vapor.

What we can say is this: a creator directing 11,800 viewers toward a "therapy" highlight on Instagram, without making any audible or legible claim in the actual video, is a pattern worth noticing. The content strategy here is to tease, not to inform.

Does the science back this up?

There is nothing to test against the literature. No claim was made. But since the video exists in a TRT content category and sends viewers toward a therapy program, it is worth grounding what legitimate TRT science actually looks like, so viewers arriving here have a baseline.

Testosterone replacement therapy for documented hypogonadism, defined as consistently low serum testosterone plus clinical symptoms, has a real evidence base. Bhasin et al. (2010, New England Journal of Medicine) established that TRT in hypogonadal men improves lean mass, sexual function, and bone density. A 2018 Cochrane review by Huo et al. found modest but real improvements in quality of life scores. The key word throughout this literature is "hypogonadal." TRT for men with normal testosterone levels does not carry the same benefit profile, and the risk calculus changes substantially, including elevated hematocrit, cardiovascular strain, and suppression of endogenous production.

None of this is what the transcript addresses, because the transcript addresses nothing.

What did they get wrong (or right)?

Getting something wrong requires actually saying something. This transcript does not clear that bar. What the creator gets wrong, if we're being direct, is the assumption that pointing viewers toward an off-platform "therapy" program via a content-free teaser video is an acceptable way to communicate health information.

The phrase "we're one of the best friends for seeing the past" might be a mangled version of a testimonial or a legacy claim about the program. If so, that kind of self-promotional framing without supporting data is a red flag regardless of what therapy is being sold. The American Urological Association's 2018 guidelines on testosterone deficiency explicitly call for baseline labs, symptom assessment, and ongoing monitoring as prerequisites for TRT. A TikTok-to-Instagram funnel skips all of that due diligence.

There is no credit to give here for accuracy, because there is no accuracy to evaluate. That absence is itself informative.

What should you actually know?

If you landed on this video because you are genuinely curious about TRT, here is what the evidence actually supports. Hypogonadism affects roughly 2-4% of men, according to Araujo et al. (2007, Archives of Internal Medicine), and that population has legitimate clinical options. Diagnosis requires two morning serum testosterone measurements below 300 ng/dL, per Endocrine Society guidelines (Bhasin et al., 2018), combined with symptoms like fatigue, low libido, or erectile dysfunction.

TRT is not a fitness upgrade for men with normal hormone levels. A 2020 study by Lincoff et al. published preliminary cardiovascular safety data that has since fed into ongoing debate about long-term cardiac risk, particularly for older men or those with pre-existing conditions. The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine) found non-inferior cardiovascular outcomes for TRT versus placebo in symptomatic hypogonadal men, which is reassuring for the right patient, but that patient has a diagnosis, not just a goal.

Any platform, including this one, that offers "therapy" without a documented diagnostic process is selling something other than medicine. Ask to see the lab protocol before anything else.